mytolac 120 mg inj. sol. i.v. pre-filled syr.
amdipharm ltd. - lanreotide acetate 133,33 mg - eq. lanreotide 120 mg - solution for injection in pre-filled syringe - 120 mg - lanreotide acetate 133.33 mg - lanreotide
somatuline autogel prolonged release solution for injection in a pre-filled syringe 120 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 149.4mg eqv lanreotide - injection, solution - 120 mg - lanreotide acetate 149.4mg eqv lanreotide 120 mg
somatuline autogel prolonged release solution for injection in a pre-filled syringe 60 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 77.9mg eqv lanreotide - injection, solution - 60 mg - lanreotide acetate 77.9mg eqv lanreotide 60 mg
somatuline autogel prolonged release solution for injection in a pre-filled syringe 90 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 113.6mg eqv lanreotide - injection, solution - 90 mg - lanreotide acetate 113.6mg eqv lanreotide 90 mg
somatuline la 30mg powder and solvent for suspension for injection vials
ipsen ltd - lanreotide acetate - powder and solvent for suspension for injection - 30mg
somatuline autogel
new zealand medical & scientific ltd - lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate) - solution for injection - 24.6 mg/ml - active: lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate) excipient: glacial acetic acid water for injection - latest regulatory activity
somatuline la
ipsen pty ltd - lanreotide acetate -
somatuline autogel 120mg prolonged-release solution for injection in a pre-filled syringe
zuellig pharma sdn bhd - lanreotide acetate; lanreotide acetate -
somatuline autogel 60mg prolonged-release solution for injection in a pre-filled syringe
zuellig pharma sdn bhd - lanreotide acetate; lanreotide acetate -
somatuline autogel 90mg prolonged-release solution for injection in a pre-filled syringe
zuellig pharma sdn bhd - lanreotide acetate; lanreotide acetate -